Published 2 days ago • loading... • Updated 2 days ago
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation
Rosen said it is preparing a securities class action for investors after Anavex allegedly issued materially misleading business information.
On September 20, Rosen Law Firm announced an investigation into Anavex Life Sciences Corp. on behalf of shareholders, alleging the company may have issued materially misleading business information to investors.
The investigation was prompted by Anavex's May 6 filing disclosing that its special committee terminated CEO Christopher Missling for conduct inconsistent with company policy and requested his board resignation.
Rosen Law Firm has recovered billions of dollars for investors and secured over $438 million in 2019 alone, maintaining top-4 rankings in securities class actions since 2013.
Investors who purchased Anavex securities may join the class action without upfront costs through a contingency fee arrangement by contacting attorney Phillip Kim at 866-767-3653 or case@rosenlegal.com.
Rosen Law Firm emphasizes selecting qualified counsel with proven track records in securities litigation; founding partner Laurence Rosen was named a Titan of Plaintiffs Bar by law360 in 2020.